{"title":"济得注射液投入使用","authors":["郑剑"],"dates":[{"year":1996,"month":11,"day":27}],"parts":[{"type":"paragraph","text":"济得注射液投入使用"},{"type":"paragraph","text":"本报讯防治厌氧菌感染的新一代产品济得注射液近日由湖北广济药业股份有限公司研制成功并投入使用。厌氧菌为人类感染疾病的重要致病菌。以往使用的甲硝唑疗程长，用药后毒副作用大。济得注射液明显优于甲硝唑，是防治厌氧菌感染的理想新药。（郑剑）"}],"comments":[],"comment_pivots":[],"description":"","page_start":5,"page_end":5}